CIML, Canceropôle PACA
A therapeutic revolution is happening.
Cancéropôle PACA joins forces with Marseille-Immunopôle to the fight against cancer, through the structuration of ground-breaking platforms and the support of ambitious and strategic academic and translational research programs in the field of anti-tumoral immunotherapy.
A therapeutic revolution is happening.#research
This is the DNA of the cluster to feed local excellence, including, of course, fundamental and applied immunology, and to support the emergence of sector initiatives with strong potential.
Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team.
Marseille Immunopole should allow us now to accelerate the development of therapeutic antibodies, the new drugs that are changing the course of cancer treatment.
AMU, IPC, CRCM
HalioDx is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.